The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...

The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections to treat several inflammatory conditions. Adults and certain children can receive this medication to treat ...

Cosentyx (secukinumab) has potential interactions with other prescription medications and certain vaccines. For example, Cosentyx may interact with cyclosporine and other immunosuppressant drugs and ...

Studies show that Cosentyx is a safe and effective medication that doesn’t directly cause brain or nerve problems. While some older medications had warnings about nerve issues, Cosentyx is a different ...

Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept.

DENVER (KDVR) — A Colorado board continues reviewing the cost of prescription drugs, and public feedback is wanted about the latest two under review. Cosentyx, which treats psoriasis, and Stelara, for ...